Signal peptidase complex catalytic subunit SEC11A upregulation is a biomarker of poor prognosis in patients with head and neck squamous cell carcinoma

A Ductal-Cell-Related Risk Model Integrating Single-Cell and Bulk Sequencing Data Predicts the Prognosis of Patients With Pancreatic Adenocarcinoma

(2022) Xitao Wang et al.   Frontiers in Genetics

MiR‐873‐5p modulates the progression of tongue squamous cell carcinoma via targeting SEC11A

(2021) Yao Yao et al.   ORAL DISEASES

Structure of the human signal peptidase complex reveals the determinants for signal peptide cleavage

(2021) A. Manuel Liaci et al.   MOLECULAR CELL

Visualizing and interpreting cancer genomics data via the Xena platform

(2020) Mary J. Goldman et al.   NATURE BIOTECHNOLOGY

TIMER2.0 for analysis of tumor-infiltrating immune cells

(2020) Taiwen Li et al.   NUCLEIC ACIDS RESEARCH

Design, synthesis and pharmacological evaluation of 4-(3-chloro-4-(3-cyclopropylthioureido)-2-fluorophenoxy)-7-methoxyquinoline-6-carboxamide (WXFL-152): a novel triple-angiokinase inhibitor for cancer therapy

(2020) Yuqin Yao et al.   Acta Pharmaceutica Sinica B

SPC18 Expression Is an Independent Prognostic Indicator of Patients with Esophageal Squamous Cell Carcinoma

(2020) Yuji Yamamoto et al.   PATHOBIOLOGY

Head and neck squamous cell carcinoma

(2020) Daniel E. Johnson et al.   Nature Reviews Disease Primers

HPV, tumour metabolism and novel target identification in head and neck squamous cell carcinoma

(2019) Jason C. Fleming et al.   BRITISH JOURNAL OF CANCER

Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review

(2019) Barbora Peltanova et al.   Molecular Cancer

Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor

(2019) Dehong Yan et al.   Frontiers in Immunology

Bioinformatic analysis of the prognostic value and potential regulatory network of FOXF1 in papillary thyroid cancer

(2019) Yi Gu et al.   BIOFACTORS

Immunotherapies and Future Combination Strategies for Head and Neck Squamous Cell Carcinoma

(2019) Valerie Cristina et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

PI3K/AKT/mTOR signaling as a molecular target in head and neck cancer

(2019) Franziska E. Marquard et al.   BIOCHEMICAL PHARMACOLOGY

Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival

(2018) C. Dubot et al.   EUROPEAN JOURNAL OF CANCER

Inflammation-induced myeloid-derived suppressor cells associated with squamous cell carcinoma of the head and neck

(2016) Wen-Cheng Chen et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment

(2016) Vinit Kumar et al.   TRENDS IN IMMUNOLOGY

Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma

(2016) Paolo Bossi et al.   Oncotarget

Comprehensive genomic characterization of head and neck squamous cell carcinomas

(2015)   NATURE

EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection

(2015) Kyle C. Cuneo et al.   PHARMACOLOGY & THERAPEUTICS

Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas

(2013) Sungjae Hwang et al.   CANCER

Signal peptidase complex 18, encoded by SEC11A, contributes to progression via TGF-α secretion in gastric cancer

(2013) N Oue et al.   ONCOGENE